GEARING UP FOR WWJ 950'S THAW RADIOTHON: BID IN THE ONLINE AUCTION NOW!  

Cell Treatment

Aastrom To Refocus Research On Dilated Cardiomyopathy, Cut StaffAastrom Biosciences Inc., a developer of patient-specific expanded multicellular therapies for the treatment of severe chronic diseases, announced a strategic change in its research and development programs to focus on the clinical development of its lead product, ixmyelocel-T, for the treatment of dilated cardiomyopathy.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen